...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

"I'm still looking/waiting for a better price entry. Let's see where it goes" ???

zens done PP's for around $2 - ZHCLF is trading at .36 pennies - buyout rumors suggest $20?? so just what sort of "a better price entry" are you expecting/looking for, for goodness sakes? 

Share
New Message
Please login to post a reply